Subjects with concomitant FLG mutations and AD (FLG+/AD+) showed the highest symptom prevalence, and a significantly higher prevalence of scaling, fissures and current HE than the FLG−/AD+ subgroup. This evidence concerns the gene FLG and hereditary elliptocytosis.